These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15211328)

  • 1. Focus on high-density lipoproteins in reducing cardiovascular risk.
    Brewer HB
    Am Heart J; 2004 Jul; 148(1 Suppl):S14-8. PubMed ID: 15211328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease.
    Brewer HB; Remaley AT; Neufeld EB; Basso F; Joyce C
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1755-60. PubMed ID: 15319263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection.
    Meyers CD; Kashyap ML
    Curr Opin Cardiol; 2004 Jul; 19(4):366-73. PubMed ID: 15218398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting high-density lipoproteins: update on a promising therapy.
    Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
    Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.
    Tall AR
    J Intern Med; 2008 Mar; 263(3):256-73. PubMed ID: 18271871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Postgrad Med J; 2008 Nov; 84(997):590-8. PubMed ID: 19103817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages.
    Uto-Kondo H; Ayaori M; Ogura M; Nakaya K; Ito M; Suzuki A; Takiguchi S; Yakushiji E; Terao Y; Ozasa H; Hisada T; Sasaki M; Ohsuzu F; Ikewaki K
    Circ Res; 2010 Mar; 106(4):779-87. PubMed ID: 20075335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
    Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
    Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
    Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases.
    Ikenaga M; Higaki Y; Saku K; Uehara Y
    J Atheroscler Thromb; 2016; 23(4):385-94. PubMed ID: 26830201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of high-density lipoprotein cholesterol metabolism and reverse cholesterol transport.
    Hersberger M; von Eckardstein A
    Handb Exp Pharmacol; 2005; (170):537-61. PubMed ID: 16596814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
    Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
    Cavelier C; Lorenzi I; Rohrer L; von Eckardstein A
    Biochim Biophys Acta; 2006 Jul; 1761(7):655-66. PubMed ID: 16798073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of statins on high-density lipoproteins.
    Schaefer EJ; Asztalos BF
    Curr Atheroscler Rep; 2006 Jan; 8(1):41-9. PubMed ID: 16455013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia.
    Bellanger N; Orsoni A; Julia Z; Fournier N; Frisdal E; Duchene E; Bruckert E; Carrie A; Bonnefont-Rousselot D; Pirault J; Saint-Charles F; Chapman MJ; Lesnik P; Le Goff W; Guerin M
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1675-81. PubMed ID: 21527752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.